Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 13Lymphoma, Non-Hodgkin 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Leukemia, Lymphocytic, Chronic, B-Cell 6Sarcoma 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 5Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Hematologic Neoplasms 3Hematologic Diseases 3Breast Neoplasms 3Testicular Neoplasms 2Teratoma 2Retinoblastoma 2Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Bevacizumab 69Sorafenib 66lenvatinib 59durvalumab 38sintilimab 33Nivolumab 32tislelizumab 28atezolizumab 28pembrolizumab 27Oxaliplatin 26tremelimumab 23apatinib 22Fluorouracil 22Radiosurgery 20regorafenib 19camrelizumab 18Doxorubicin 18cabozantinib 16Leucovorin 16Capecitabine 16Radiotherapy 14Folfox protocol 14donafenib 13Gemcitabine 13Cisplatin 12toripalimab 11Erlotinib Hydrochloride 10spartalizumab 8anlotinib 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Hepatocellular × Mesna × Clear all
NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡